IDiyas

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Peter D Williams

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 5.4

ph-index = 11

Forward Citations = 387(Granted Patents)


Location History:

  • Lansdale, PA (US) (1991)
  • Rahway, NJ (US) (2017)
  • Harleysville, PA (US) (1993 - 2020)

Company Filing History:

goldMedal25 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal10 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal4 out of 40 
 
Merck Canada Inc.
 patents
4. 1 out of 10 
 
Msd R&d (china) Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1991-2020

Loading Chart...
Loading Chart...
35 patents (USPTO):
1. 10696639 - Heterocyclic compounds as HIV protease inhibitors (2020-06-30),
2. 10138255 - Piperazine derivatives as HIV protease inhibitors (2018-11-27),
3. 9994587 - HIV protease inhibitors (2018-06-12),
4. 9840478 - Piperazine derivatives as HIV protease inhibitors (2017-12-12),
5. 9834526 - HIV protease inhibitors (2017-12-05),
6. 9737545 - HIV protease inhibitors (2017-08-22),
7. 9550786 - 4-fluoropiperidine orexin receptor antagonists (2017-01-24),
8. 9315475 - HIV protease inhibitors (2016-04-19),
9. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors (2014-10-28),
10. 8513234 - HIV integrase inhibitors (2013-08-20),
11. 7820680 - HIV integrase inhibitors (2010-10-26),
12. 7619086 - HIV integrase inhibitors (2009-11-17),
13. 7517532 - Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors (2009-04-14),
14. 7476666 - HIV integrase inhibitors (2009-01-13),
15. 7144899 - Thrombin inhibitors (2006-12-05),

Title: Innovations in HIV Research: The Contributions of Peter D Williams

Introduction

Peter D Williams, based in Harleysville, Pennsylvania, is a prominent inventor in the pharmaceutical field with an impressive portfolio of 35 patents. His primary focus has been on developing innovative compounds that target HIV protease, contributing significantly to the ongoing battle against HIV and AIDS.

Latest Patents

Among his most notable recent inventions are:

1. **Heterocyclic compounds as HIV protease inhibitors** - This invention is directed to compounds of Formula (I), pharmaceutical compositions comprising the same, and their use in inhibiting HIV protease. It focuses on the inhibition of HIV replication, prevention of HIV infection, and the treatment and delay in the onset or progression of AIDS.

2. **Piperazine derivatives as HIV protease inhibitors** - Similar to his previous patent, this invention centers on compounds of Formula I and their applications in inhibiting HIV protease, managing HIV replication, and offering prophylaxis and treatment options for HIV and AIDS.

Career Highlights

Peter D Williams has made substantial contributions during his tenure at notable companies, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work has not only advanced medical science but also brought hope to countless individuals affected by HIV.

Collaborations

Throughout his career, Williams has collaborated with respected professionals in the field, including Roger M Freidinger and John A McCauley. Together, they have worked on groundbreaking research, further solidifying their impacts on HIV treatment methodologies.

Conclusion

Peter D Williams exemplifies the innovative spirit of the pharmaceutical industry, with a significant focus on improving HIV treatment options. His dedication to research and development continues to pave the way for new therapeutic strategies, demonstrating the essential role of inventors in the fight against global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…